放射線医薬品の世界市場2023~2028

◆英語タイトル:Radiopharmaceuticals Market Report by Product Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, Endocrinology, and Others), End Use (Hospitals and Clinics, Research Institutes, Diagnostic Centers), and Region 2023-2028

IMARCが発行した調査報告書(IMARC23DCB0401)◆商品コード:IMARC23DCB0401
◆発行会社(リサーチ会社):IMARC
◆発行日:2023年11月
◆ページ数:140
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single UserUSD2,999 ⇒換算¥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算¥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算¥759,848見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の放射線医薬品市場規模は2022年に52億ドルに達しました。今後、IMARC Groupは、市場は2028年までに73億ドルに達し、2022年から2028年の間に5.8%の成長率(CAGR)を示すと予測しています。
放射線医薬品は放射性同位元素からなる独自の製剤で、臨床分野で診断や治療に使用されます。これらの医薬品は、核医学を専門とする医療専門家である放射線薬剤師によって投与されます。錠剤の形で服用されるか、患者の体の静脈や空洞に注射されます。放射線医薬品が標的とする場所に到達すると、放射性薬剤を放出して腫瘍細胞を破壊します。その結果、放射線医薬品は甲状腺がん、脳腫瘍、リンパ腫、骨に転移したその他のがんの治療に使用されています。

放射線医薬品市場の動向:
高齢化社会の到来と不健康な食事パターンによる癌性疾患の増加は、世界中で放射線医薬品の使用が増加している主な要因です。これとは別に、診断センター数の増加も市場を支えています。さらに、がん細胞の発生に関与する特定のタンパク質や遺伝子を標的とする薬剤を利用する疾患標的がん治療を提案する腫瘍専門医の数が増加していることも、全体的な売上にプラスの影響を与えています。さらに、放射線標識ペプチドやモノクローナル抗体の癌腫瘍の診断や治療への利用が、医療費の増加とともに市場の成長を強化しています。その他、体内の放射能を追跡してがん細胞の有無を判定するために腫瘍医が放射線医薬品を使用するケースが増えていることや、陽電子放射断層撮影(PET)や単光子放射コンピュータ断層撮影(SPECT)スキャンへのシフトが進んでいることも、市場の成長を促進すると予想される主な要因です。

主な市場セグメンテーション
IMARC Groupは、世界の放射線医薬品市場レポートの各サブセグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供しています。当レポートでは、製品タイプ、用途、最終用途に基づいて市場を分類しています。

製品タイプ別
診断用核医学
治療用核医学

用途別
腫瘍学
循環器
神経学
内分泌学
その他

エンドユース別
病院・クリニック
研究機関
診断センター

地域別
北米
米国
カナダ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
インドネシア
その他
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他
ラテンアメリカ
ブラジル
メキシコ
その他
中東・アフリカ

競争環境
業界の競争環境は、Advanced Accelerator Applications (Novartis AG)、Bayer AG、Bracco S.p.A.、Cardinal Health Inc.、Curium Pharma、General Electric Company、IBA RadioPharma Solutions、Jubilant Pharma Limited、Lantheus Medical Imaging Inc.、Nordion Inc. (Sotera Health)、NTP Radioisotopes SOC Ltd.、PharmaLogic Holdings Corp.、Siemens AGなどの主要企業のプロフィールとともに調査されています。

本レポートで扱う主な質問
1. 2022年の世界の放射線医薬品市場規模は?
2. 2023-2028年の世界の放射線医薬品市場の成長率は?
3. COVID-19が世界の放射線医薬品市場に与えた影響は?
4. 放射線医薬品の世界市場を牽引する主要因は?
5. 放射線医薬品の世界市場の製品タイプ別内訳は?
6. 放射線医薬品の世界市場の用途別内訳は?
7. 放射線医薬品の世界市場の用途別内訳は?
8. 放射線医薬品の世界市場における主要地域は?
9. 放射線医薬品の世界市場における主要プレイヤー/企業は?

1. 序論
2. 範囲・調査手法
3. エグゼクティブサマリー
4. イントロダクション
5. 世界の放射線医薬品市場
6. 放射線医薬品の世界市場規模:製品タイプ別
7. 放射線医薬品の世界市場規模:用途別
8. 放射線医薬品の世界市場規模:エンドユーザー別
9. 放射線医薬品の世界市場規模:地域別
10. SWOT分析
11. バリューチェーン分析
12. ファイブフォース分析
13. 価格分析
14. 競争状況

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Radiopharmaceuticals Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Diagnostic Nuclear Medicine
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Therapeutic Nuclear Medicine
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Application
7.1 Oncology
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiology
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Neurology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Endocrinology
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by End Use
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Research Institutes
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Diagnostic Centers
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Advanced Accelerator Applications (Novartis AG)
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Bayer AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bracco S.p.A.
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 Cardinal Health Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Curium Pharma
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 General Electric Company
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 IBA RadioPharma Solutions
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Jubilant Pharma Limited
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.9 Lantheus Medical Imaging Inc
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.10 Nordion Inc. (Sotera Health)
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 SWOT Analysis
14.3.11 NTP Radioisotopes SOC Ltd
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 PharmaLogic Holdings Corp.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.13 Siemens AG
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis

Figure 1: Global: Radiopharmaceuticals Market: Major Drivers and Challenges
Figure 2: Global: Radiopharmaceuticals Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Radiopharmaceuticals Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Radiopharmaceuticals Market: Breakup by Product Type (in %), 2022
Figure 5: Global: Radiopharmaceuticals Market: Breakup by Application (in %), 2022
Figure 6: Global: Radiopharmaceuticals Market: Breakup by End Use (in %), 2022
Figure 7: Global: Radiopharmaceuticals Market: Breakup by Region (in %), 2022
Figure 8: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Radiopharmaceuticals (Diagnostic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Radiopharmaceuticals (Therapeutic Nuclear Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Radiopharmaceuticals (Oncology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Radiopharmaceuticals (Oncology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Radiopharmaceuticals (Cardiology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Radiopharmaceuticals (Cardiology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Radiopharmaceuticals (Neurology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Radiopharmaceuticals (Neurology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Radiopharmaceuticals (Endocrinology) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Radiopharmaceuticals (Endocrinology) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Radiopharmaceuticals (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Radiopharmaceuticals (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Radiopharmaceuticals (Hospitals and Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Radiopharmaceuticals (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Radiopharmaceuticals (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Radiopharmaceuticals (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Radiopharmaceuticals (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Radiopharmaceuticals (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: North America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: North America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: United States: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: United States: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Canada: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Canada: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Asia-Pacific: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Asia-Pacific: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: China: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: China: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Japan: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Japan: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: India: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: India: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: South Korea: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: South Korea: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Australia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Australia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Indonesia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Indonesia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Europe: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Europe: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Germany: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Germany: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: France: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: France: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: United Kingdom: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: United Kingdom: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: Italy: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: Italy: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Spain: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Spain: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Russia: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Russia: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Latin America: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Latin America: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Brazil: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Brazil: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Mexico: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Mexico: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Others: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Others: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Middle East and Africa: Radiopharmaceuticals Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Middle East and Africa: Radiopharmaceuticals Market: Breakup by Country (in %), 2022
Figure 76: Middle East and Africa: Radiopharmaceuticals Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Global: Radiopharmaceuticals Industry: SWOT Analysis
Figure 78: Global: Radiopharmaceuticals Industry: Value Chain Analysis
Figure 79: Global: Radiopharmaceuticals Industry: Porter's Five Forces Analysis

Table 1: Global: Radiopharmaceuticals Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Radiopharmaceuticals Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
Table 3: Global: Radiopharmaceuticals Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 4: Global: Radiopharmaceuticals Market Forecast: Breakup by End Use (in Million US$), 2023-2028
Table 5: Global: Radiopharmaceuticals Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Radiopharmaceuticals Market: Competitive Structure
Table 7: Global: Radiopharmaceuticals Market: Key Players

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 放射線医薬品の世界市場2023~2028(Radiopharmaceuticals Market Report by Product Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Application (Oncology, Cardiology, Neurology, Endocrinology, and Others), End Use (Hospitals and Clinics, Research Institutes, Diagnostic Centers), and Region 2023-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆